Millennium Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,441,735
| Closed | -$8.42M | – | 7326 |
|
|
2022
Q4 | $8.42M | Buy |
1,441,735
+122,227
| +9% | +$643K | ﹤0.01% | 2318 |
|
|
2022
Q3 | $8.84M | Buy |
1,319,508
+76,932
| +6% | +$466K | 0.01% | 2293 |
|
|
2022
Q2 | $5.23M | Sell |
1,242,576
-2,836
| -0.2% | -$11.2K | ﹤0.01% | 2763 |
|
|
2022
Q1 | $4.2M | Sell |
1,245,412
-103,817
| -8% | -$329K | ﹤0.01% | 3121 |
|
|
2021
Q4 | $4.25M | Buy |
1,349,229
+221,599
| +20% | +$737K | ﹤0.01% | 3073 |
|
|
2021
Q3 | $3.69M | Sell |
1,127,630
-153,637
| -12% | -$538K | ﹤0.01% | 3237 |
|
|
2021
Q2 | $5.41M | Buy |
1,281,267
+274,027
| +27% | +$1.16M | ﹤0.01% | 2658 |
|
|
2021
Q1 | $5.03M | Buy |
1,007,240
+116,987
| +13% | +$945K | ﹤0.01% | 2563 |
|
|
2020
Q4 | $11.3M | Sell |
890,253
-151,630
| -15% | -$1.73M | 0.01% | 1603 |
|
|
2020
Q3 | $10.2K | Sell |
1,041,883
-177,855
| -15% | -$1.75M | 0.01% | 1226 |
|
|
2020
Q2 | $12.1M | Buy |
1,219,738
+108,798
| +10% | +$1.04M | 0.02% | 1077 |
|
|
2020
Q1 | $9.82M | Buy |
1,110,940
+709,310
| +177% | +$6.99M | 0.02% | 868 |
|
|
2019
Q4 | $3.71M | Buy |
401,630
+33,305
| +9% | +$236K | ﹤0.01% | 2163 |
|
|
2019
Q3 | $2.17M | Sell |
368,325
-156,239
| -30% | -$1.66M | ﹤0.01% | 2393 |
|
|
2019
Q2 | $6.29M | Sell |
524,564
-302,304
| -37% | -$3.25M | 0.01% | 1598 |
|
|
2019
Q1 | $9.98M | Sell |
826,868
-184,885
| -18% | -$2.72M | 0.01% | 1250 |
|
|
2018
Q4 | $12.7M | Buy |
1,011,753
+471,312
| +87% | +$6.51M | 0.02% | 979 |
|
|
2018
Q3 | $8.02M | Sell |
540,441
-118,711
| -18% | -$1.87M | 0.01% | 1466 |
|
|
2018
Q2 | $11.1M | Buy |
659,152
+227,269
| +53% | +$4.41M | 0.01% | 1245 |
|
|
2018
Q1 | $9.89M | Sell |
431,883
-294,002
| -41% | -$6.54M | 0.01% | 1331 |
|
|
2017
Q4 | $18.8M | Buy |
725,885
+503,066
| +226% | +$10.1M | 0.03% | 940 |
|
|
2017
Q3 | $3.29M | Buy |
222,819
+36,651
| +20% | +$532K | 0.01% | 1897 |
|
|
2017
Q2 | $2.6M | Sell |
186,168
-632
| -0.3% | -$9.31K | ﹤0.01% | 1925 |
|
|
2017
Q1 | $3.19M | Sell |
186,800
-46,096
| -20% | -$553K | 0.01% | 1728 |
|
|
2016
Q4 | $2.4M | Buy |
232,896
+115,934
| +99% | +$1.06M | 0.01% | 1777 |
|
|
2016
Q3 | $1.18M | Sell |
116,962
-167,459
| -59% | -$1.83M | ﹤0.01% | 2194 |
|
|
2016
Q2 | $3.19M | Sell |
284,421
-283,447
| -50% | -$3.61M | 0.01% | 1528 |
|
|
2016
Q1 | $7.76M | Sell |
567,868
-347,757
| -38% | -$5.01M | 0.02% | 984 |
|
|
2015
Q4 | $17.4M | Sell |
915,625
-55,394
| -6% | -$1.2M | 0.04% | 632 |
|
|
2015
Q3 | $18.2M | Buy |
971,019
+406,209
| +72% | +$6.9M | 0.04% | 607 |
|
|
2015
Q2 | $8.41M | Buy |
564,810
+192,988
| +52% | +$2.94M | 0.02% | 1084 |
|
|
2015
Q1 | $5.63M | Buy |
371,822
+129,742
| +54% | +$1.81M | 0.01% | 1351 |
|
|
2014
Q4 | $3.23M | Buy |
+242,080
| New | +$3.13M | 0.01% | 1652 |
|
|
2014
Q3 | – | Sell |
-20,676
| Closed | -$209K | – | 4089 |
|
|
2014
Q2 | $209K | Buy |
20,676
+5,396
| +35% | +$52.1K | ﹤0.01% | 3104 |
|
|
2014
Q1 | $206K | Buy |
+15,280
| New | +$216K | ﹤0.01% | 3187 |
|
Millennium Management's CNCE Position: Q1 2023 in Review
Millennium Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 1,441,735 shares — an estimated $8.42M sold.
Millennium Management first reported a position in CNCE in Q1 2014 and held it in 35 quarters. The position peaked at $18.8M in Q4 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Millennium Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Millennium Management sold 1,441,735 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $8.42M.
- Millennium Management first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 35 quarters.
- Millennium Management's Concert Pharmaceuticals, Inc. position peaked at $18.8M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.